Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2020
International regulators stress value of safe and effective vaccines
18 June 2020 - EMA has endorsed two statements about the importance, safety and effectiveness of vaccines published today by the ...
Posted by Michael Wonder on 09 Jun 2020
Lamotrigine concerns not addressed
8 June 2020 - A Dunedin mother whose son died soon after his usual epilepsy drug was replaced by a ...
Posted by Michael Wonder on 07 Jun 2020
Kiwis affected by epilepsy drug switch feel let down by PHARMAC review
6 June 2020 - A woman whose son died of a seizure after his epilepsy medication was switched says findings ...
Posted by Michael Wonder on 31 May 2020
COVID-19: reminder of the risks of chloroquine and hydroxychloroquine
29 May 2020 - The EMA is reminding health care professionals to closely monitor patients with COVID-19 who are receiving ...
Posted by Michael Wonder on 28 May 2020
Fauci warns about hydroxychloroquine
27 May 2020 - Top administration expert airs differences with Trump on pandemic response. ...
Posted by Michael Wonder on 28 May 2020
Off-label drugs a risky business
28 May 2020 - Three years ago a 64cm blood clot caused by a drug used to treat acne, Diane ...
Posted by Michael Wonder on 25 May 2020
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
26 May 2020 - The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to ...
Posted by Michael Wonder on 27 Apr 2020
Health Canada issues warning against use of hydroxychloroquine for COVID-19
26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...
Posted by Michael Wonder on 25 Apr 2020
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
24 April 2020 - Close supervision is strongly recommended. ...
Posted by Michael Wonder on 24 Apr 2020
Reporting suspected side effects of medicines in patients with COVID-19
24 April 2020 - EMA and the national competent authorities are reminding patients with confirmed or suspected coronavirus disease (COVID-19) ...
Posted by Michael Wonder on 23 Apr 2020
COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine
23 April 2020 - Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated ...
Posted by Michael Wonder on 28 Mar 2020
EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic
27 March 2020 - EMA is aware of recent media reports and publications which question whether some medicines, for instance ...
Posted by Michael Wonder on 09 Mar 2020
Reports of epilepsy drug harm increase 30-fold since PHARMAC switches brands
7 March 2020 - Reports of people harmed while taking epilepsy drugs is 30 times what it was before PHARMAC ...
Posted by Michael Wonder on 25 Jan 2020
Bipolar disorder patients suffer 'terrible' side effects after PHARMAC drug brand switch
25 January 2020 - A woman with bipolar disorder says she was "crying everyday" and having thoughts of suicide after ...
Posted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...